![Romuald Corbau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Romuald Corbau worked as Chief Scientific Officer at Freeline Therapeutics Holdings Ltd. from 2020 to 2021.
Dr. Corbau worked as Chief Scientific Officer at GenEdit, Inc. Dr. Corbau worked as Chief Scientific Officer at Adverum Biotechnologies, Inc. from 2024 to 2025.
Dr. Corbau graduated from Université des Sciences et Technologies de Lille.
| Unternehmen | Position | Ende |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.12.2025 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 20.08.2021 |
GenEdit, Inc.
 GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Université des Sciences et Technologies de Lille
 Université des Sciences et Technologies de Lille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
GenEdit, Inc.
GenEdit, Inc. BiotechnologyHealth Technology Develops next generation therapeutics for genetic diseases | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
